John Pinching from PharmaTimes - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices		SMC recommends Yselty for treating uterine fibroids - 6 days ago Scottish medicines consortium approves CAR T-cell therapy for blood cancer - 6 days ago New study to assess mpox vaccine in pregnant women and infants - 10 days ago Elsevier backs Pistoia Alliance for AI in drug discovery - 10 days ago Arcellx to present positive data on multiple myeloma treatments - 11 days ago MHRA grants approval for bladder cancer drug erdafitinib - 11 days ago Dr Jane Rhodes - 12 days ago Anthony Hemmerdinger - 13 days ago Laura Vergani - 25 days ago NICE recommendation for new Alexion PNH treatment - 25 days ago Darzalex subcutaneous regimen approved by European Commission - 25 days ago Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug - 25 days ago Celltrion unveils promising dose escalation results for subcutaneous infliximab - about 1 month ago Alleo and Ubiquigent unite to accelerate drug discovery - about 1 month ago Lundbeck to acquire Longboard Pharmaceuticals in strategic deal - about 1 month ago Transgene’s cancer vaccine trial shows mixed results - about 1 month ago IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients - about 2 months ago ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - about 2 months ago Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy - about 2 months ago AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference - about 2 months ago EC approves Yuvanci for pulmonary arterial hypertension treatment - about 2 months ago Dr Alex Dickinson - about 2 months ago World Sepsis Day 2024 highlights need for better sepsis treatments - 2 months ago Nxera and Cancer Research UK to present promising cancer drug trial at ESMO - 2 months ago HRT linked to reduced psychosis relapse risk in menopausal women - 2 months ago Centessa reports positive phase 1 clinical data for ORX750 - 2 months ago Scotland first in UK to approve new myeloma treatment - 2 months ago AI-Powered chest X-Rays detect lung cancer early - 2 months ago Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease - 2 months ago APL and CurifyLabs partner to support patients with 3D printing medicine technology - 2 months ago ChatGPT outperforms trainee doctors in assessing respiratory illness in children - 2 months ago Eli Lilly’s once-weekly insulin shows promise in phase 3 trials - 2 months ago AMBLor prognostic melanoma biomarker receives UKCA Mark - 2 months ago European Commission grants orphan drug designation for Vivet’s VTX-806 - 2 months ago Simon Jones - 2 months ago Dr Jonathan Appleby - 2 months ago Adam Rosenberg - 3 months ago Geoffrey Hodge - 3 months ago James Halle - 3 months ago Steve Hopkinson - 3 months ago Sounds great – HCA milestone for PharmaTimes Communications Awards - 4 months ago Dr Rafiq Hasan - 4 months ago Deborah Knobelman - 5 months ago Professor Bjoern Schelter - 5 months ago Serac’s imaging agent marks a breakthrough in endometriosis detection - 5 months ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 5 months ago Amgen’s trial brings new hope for IgG4-RD patients - 5 months ago Alchemab receives funding boost for Parkinson’s research - 5 months ago Happy anniversary! - 6 months ago Helen Dent - 7 months ago
2	Anaelle Tannen PharmaTimes		World Sepsis Day 2024 highlights need for better sepsis treatments - 2 months ago